Clinical Case of the Novel Coronavirus Infection with the Development of Cardiovascular Complications Against the Background of Comorbid Pathology
https://doi.org/10.31550/1727-2378-2022-21-6-25-28
Abstract
Objective of the Paper: To demonstrate a clinical case of a severe course of the novel coronavirus infection with the development of cardiovascular complications against the background of concomitant comorbid diseases.
Key points. A case of a novel coronavirus infection is presented with a description of the clinical course and the results of laboratory and instrumental examination. In the clinical picture, in addition to massive damage of the lung tissue, according to computed tomography, firsttime ischemic stroke, atrial fibrillation, and type 2 myocardial infarction were observed, which occurred against the background of obesity, type 2 diabetes mellitus and autoimmune thyroiditis.
Conclusion. The polymorphism of the clinical picture and the various variants of manifestation of a novel coronavirus infection, taking in some cases a polysystemic character, require doctors to diagnose the disease in a timely manner and identify its potential complications at an early stage, developing in the acute period, especially in the older age group.
About the Authors
G. G. Kutelev
S.M. Kirov Military Medical Academy (a Federal Government-funded Military Educational Institution of Higher Education)
Russian Federation
Russian Federation
6 Academician Lebedev Str., St. Petersburg, 194044
N. T. Mirzoev
S.M. Kirov Military Medical Academy (a Federal Government-funded Military Educational Institution of Higher Education)
Russian Federation
Russian Federation
6 Academician Lebedev Str., St. Petersburg, 194044
V. V. Ivanov
S.M. Kirov Military Medical Academy (a Federal Government-funded Military Educational Institution of Higher Education)
Russian Federation
Russian Federation
6 Academician Lebedev Str., St. Petersburg, 194044
D. V. Cherkashin
S.M. Kirov Military Medical Academy (a Federal Government-funded Military Educational Institution of Higher Education)
Russian Federation
Russian Federation
6 Academician Lebedev Str., St. Petersburg, 194044
R. G. Makiev
S.M. Kirov Military Medical Academy (a Federal Government-funded Military Educational Institution of Higher Education)
Russian Federation
Russian Federation
6 Academician Lebedev Str., St. Petersburg, 194044
T. G. Tedeev
S.M. Kirov Military Medical Academy (a Federal Government-funded Military Educational Institution of Higher Education)
Russian Federation
Russian Federation
6 Academician Lebedev Str., St. Petersburg, 194044
References
1. Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J. et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020; 324(8): 782–93. DOI: 10.1001/jama.2020.12839COVID-19
2. Li H., Liu S.M., Yu X.H., Tang S.L. et al. Coronavirus disease 2019 (COVID-19): current status and future perspectives. Int. J. Antimicrob. Agents. 2020; 55(5): 105951. DOI: 10.1016/j.ijantimicag.2020.105951
3. Long B., Brady W., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020; 38(7): 1504–7. DOI: 10.1016/j.ajem.2020.04.048
4. Mirzoev N.T., Kutelev G.G., Pugachev M.I., Kireeva E.B. Cardiovascular complications in patients after coronavirus disease-2019. Bulletin of the Russian Military Medical Academy. 2022; 24(1): 199–208. (in Russian). DOI: 10.17816/brmma90733
5. Fisun A.Ya., Lobzin Yu.V., Cherkashin D.V., Tyrenko V.V. et al. Mechanisms of damage to the cardiovascular system in COVID-19. Annals of the Russian Academy of Medical Sciences. 2021; 76(3): 287–97. (in Russian). DOI: 10.15690/vramn1474
6. Kryukov E.V., ed. Pathogenesis and clinical manifestations of cardiovascular disorders in patients with the novel coronavirus infection (COVID-19). St. Petersburg: Veda Print; 2021. 36 p. (in Russian)
7. Rashidi F., Barco S., Kamangar F., Heresi G.A. et al. Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: prospective results from a multi-center study. Thromb. Res. 2021; 198: 135–8. DOI: 10.1016/j.thromres.2020.12.001
8. Li P., Zhao W., Kaatz S., Latack K. et al. Factors associated with risk of postdischarge thrombosis in patients with COVID-19. JAMA Netw. Open. 2021; 4(11): e2135397. DOI: 10.1001/jamanetworkopen.2021.35397
9. Khunti K., Del Prato S., Mathieu C., Kahn S.E. et al. COVID-19, hyperglycemia, and newonset diabetes. Diabetes Care. 2021; 44(12): 2645–55. DOI: 10.2337/dc21-1318
10. Tutal E., Ozaras R., Leblebicioglu H. Systematic review of COVID-19 and autoimmune thyroiditis. Travel Med. Infect. Dis. 2022; 47: 102314. DOI: 10.1016/j.tmaid.2022.102314
11. Petunina N.A., Al Taravi Ya.A., Surkova A.Yu., Martirosyan N.S. Thyroid disorders and COVID-19. Doctor.Ru. 2021; 20(2): 6–10. (in Russian). DOI: 10.31550/1727-2378-2021-20-2-6-10
12. Zhou F., Yu T., Du R., Fan G. et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054–62. DOI: 10.1016/S0140-6736(20)30566-3
13. Li Y., Li M., Wang M., Zhou Y. et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc. Neurol. 2020; 5(3): 279–84. DOI: 10.1136/svn-2020-000431
14. Talanas G., Dossi F., Parodi G. Type 2 myocardial infarction in patients with coronavirus disease 2019. J. Cardiovasc. Med. (Hagerstown). 2021; 22(7): 603–5. DOI: 10.2459/JCM.0000000000001136
Review
For citations:
Kutelev G.G., Mirzoev N.T., Ivanov V.V., Cherkashin D.V., Makiev R.G., Tedeev T.G. Clinical Case of the Novel Coronavirus Infection with the Development of Cardiovascular Complications Against the Background of Comorbid Pathology. Title. 2022;21(6):25-28. (In Russ.) https://doi.org/10.31550/1727-2378-2022-21-6-25-28
Views:
23
Email this article 